Biotech Values

[stockbettor]

MNTA 3Q earnings call transcript now available at Seeking Alpha

http://seekingalpha.com/article/233912-momenta-ceo-discusses-q3-2010-results-earnings-call-transcript

One of my mottos in small biotech investing is to avoid companies that are likely to dilute (or as the Countours and J. Geils put it, "First I look at the purse.") I doubt we will ever have this worry again with MNTA, but I found the following statement from CW reassuring:

Before I turn it over to Rick Shea to provide a financial update, I want to mention that despite the fact that we have a launch product generating substantial cash flow, we still intend to manage our finances conservatively. Last week, we engaged in a discussion of R&D productivity and were cautioned that R&D organizations frugality promotes alignment and abundance promotes bureaucracy.

At Momenta, we have every intention to build on our track record of achievement while maintaining financial discipline.